Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$959K Buy
20,555
+3,465
+20% +$162K 0.64% 49
2025
Q4
$828K Sell
17,090
-181
-1% -$8.97K 0.54% 50
2025
Q3
$818K Sell
17,271
-1,527
-8% -$73.7K 0.54% 52
2025
Q2
$907K Hold
18,798
0.63% 51
2025
Q1
$1.04M Buy
18,798
+136
+0.7% +$7.36K 0.79% 49
2024
Q4
$898K Sell
18,662
-763
-4% -$38.8K 0.7% 47
2024
Q3
$1.12M Sell
19,425
-3,084
-14% -$167K 0.84% 47
2024
Q2
$1.09M Buy
22,509
+493
+2% +$23.8K 0.8% 49
2024
Q1
$1.07M Buy
22,016
+2,225
+11% +$109K 0.8% 50
2023
Q4
$985K Buy
19,791
+4,083
+26% +$200K 0.75% 49
2023
Q3
$843K Sell
15,708
-565
-3% -$30.1K 0.73% 48
2023
Q2
$877K Sell
16,273
-85
-0.5% -$4.57K 0.71% 49
2023
Q1
$888K Buy
16,358
+2,131
+15% +$104K 0.74% 44
2022
Q4
$689K Buy
14,227
+301
+2% +$13.2K 0.58% 53
2022
Q3
$529K Sell
13,926
-1,852
-12% -$82.5K 0.44% 58
2022
Q2
$788K Sell
15,778
-431
-3% -$22.9K 0.66% 50
2022
Q1
$833K Buy
16,209
+1,184
+8% +$61.1K 0.48% 59
2021
Q4
$754K Buy
15,025
+1,386
+10% +$68.6K 0.42% 61
2021
Q3
$661K Sell
13,639
-804
-6% -$40.9K 0.44% 65
2021
Q2
$758K Sell
14,443
-67,991
-82% -$3.55M 0.5% 65
2021
Q1
$4.07M Sell
82,434
-52,141
-39% -$2.5M 0.42% 68
2020
Q4
$6.52M Sell
134,575
-41,804
-24% -$2.06M 0.69% 42
2020
Q3
$8.91M Buy
176,379
+2,728
+2% +$140K 1% 23
2020
Q2
$8.86M Buy
173,651
+90,654
+109% +$4.41M 1.15% 24
2020
Q1
$3.67M Buy
82,997
+68,936
+490% +$3.3M 0.58% 47
2019
Q4
$702K Sell
14,061
-474
-3% -$22.2K 0.09% 178
2019
Q3
$673K Sell
14,535
-332
-2% -$14.3K 0.09% 177
2019
Q2
$645K Sell
14,867
-1,801
-11% -$76.6K 0.07% 206
2019
Q1
$737K Sell
16,668
-3,080
-16% -$132K 0.1% 182
2018
Q4
$849K Sell
19,748
-5,099
-21% -$225K 0.1% 187
2018
Q3
$1.11M Sell
24,847
-388
-2% -$16.6K 0.12% 169
2018
Q2
$1.01M Sell
25,235
-34
-0.1% -$1.34K 0.13% 174
2018
Q1
$1.01M Buy
25,269
+6,839
+37% +$285K 0.12% 187
2017
Q4
$792K Buy
+18,430
New +$850K 0.1% 182

Other funds holding SNY

Banco de Sabadell's SNY Position: Q1 2026 in Review

Banco de Sabadell increased its Sanofi (SNY) stake by 20% in Q1 2026, buying an estimated $162K and bringing the position to 20,555 shares worth $959K. The position accounts for 0.64% of the portfolio, ranked #49.

Banco de Sabadell first reported a position in SNY in Q4 2017 and has held it in 34 quarters since. The position peaked at $8.91M in Q3 2020. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Banco de Sabadell held 20,555 shares of Sanofi worth $959K as of Q1 2026.
  • Banco de Sabadell bought 3,465 Sanofi shares in Q1 2026, an estimated $162K.
  • Sanofi made up 0.64% of Banco de Sabadell's portfolio in Q1 2026, its #49 holding.
  • Banco de Sabadell first reported a position in Sanofi in Q4 2017 and has held it in 34 quarters since.
  • Banco de Sabadell's Sanofi position peaked at $8.91M in Q3 2020.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Banco de Sabadell's 13F filing for Q1 2026, filed 8 May 2026.